Kymera Therapeutics KYMR
NASDAQ KYMR
$110.51 -1.49 (-1.33%)
At close: Sep 29, 2026 · 4:00 PM EDT

Kymera Therapeutics (KYMR) Operating Margin (2019 - 2026)

Updated

Kymera Therapeutics' Operating Margin came in at -116.32% for Q2 2026, up 620.50 percentage points from -736.82% a year earlier and up 128.56 percentage points from the prior quarter.

Analysis

Kymera Therapeutics (KYMR) Operating Margin (2019 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Kymera Therapeutics reported Operating Margin of -333.51%, up 364.00 percentage points year-over-year; for FY2025, it was -891.07%, down 335.26 percentage points from FY2024.

  • Operating Margin carries a five-year change of -755.02 percentage points (FY2020 to FY2025).
  • Going back by year, Operating Margin was -555.82% in FY2024 (-345.20 pp), -210.62% in FY2023 (+133.75 pp), -344.37% in FY2022 (-206.34 pp) and -138.03% in FY2021 (-1.98 pp).
  • The Q2 2026 figure represents the highest quarterly Operating Margin since Q4 2023.
  • Year-over-year, Operating Margin increased in three of the last eight quarters, with an average year-over-year change of -637.77 percentage points.
  • The fastest year-over-year change in Operating Margin over five years came in Q2 2026 (a gain of 620.50 percentage points), and the weakest in Q4 2025 (a drop of 2318.84 percentage points).
  • Business Quant data shows KYMR's Operating Margin at -244.88% (Q1 2026), -3411.01% (Q4 2025) and -3347.36% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Kymera Therapeutics 9.27 Bn 6.58 Bn - -116.32%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -116.32%
Mar 31, 2026 -244.88%
Dec 31, 2025 -3,411.01%
Sep 30, 2025 -3,347.36%
Jun 30, 2025 -736.82%
Mar 31, 2025 -336.77%
Dec 31, 2024 -1,092.17%
Sep 30, 2024 -1,927.93%
Jun 30, 2024 -198.54%
Mar 31, 2024 -562.18%
Dec 31, 2023 -40.33%
Sep 30, 2023 -1,216.35%
Jun 30, 2023 -262.72%
Mar 31, 2023 -478.83%
Dec 31, 2022 -239.36%
Sep 30, 2022 -469.92%
Jun 30, 2022 -354.44%
Mar 31, 2022 -383.84%
Dec 31, 2021 -222.55%
Sep 30, 2021 -140.82%
API Access

Kymera Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=KYMR&period=max&api_key=YOUR_API_KEY